Inicio/Acciones/CYBN

CYBN

USD

Cybin Inc. Common Shares

$6.170-0.410 (-6.231%)

Precio en Tiempo Real

Healthcare

Biotecnología

Canadá

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$6.580

Máximo

$6.830

Mínimo

$6.170

Volumen

1.59M

Fundamentos de la Empresa

Capitalización de Mercado

332.8M

Industria

Biotecnología

País

Canada

Estadísticas de Negociación

Volumen Promedio

0.74M

Bolsa

ASE

Moneda

USD

Rango de 52 Semanas

Mínimo $4.81Actual $6.170Máximo $13.88

Noticias Relacionadas

3 nov 2025 · 12:30

BusinessWire

Cybin to Participate at the 2025 Milken Institute Future of Health Summit

- Chief Medical Officer Amir Inamdar to participate in a panel on November 5, 2025 - Cybin Inc. (NYSE:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage neuropsychiatry company

Cybin to Participate at the 2025 Milken Institute Future of Health Summit

31 oct 2025 · 20:19

BusinessWire

Cybin Announces Closing of $175 Million Registered Direct Offering

Cybin Inc. (Cboe CA: CYBN) (NYSE:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery